These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8819803)

  • 1. Is it possible to prevent recurrent Crohn's disease with medical or surgical interventions?
    Mcleod RS
    Neth J Med; 1996 Feb; 48(2):68-70. PubMed ID: 8819803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease.
    McLeod RS; Wolff BG; Steinhart AH; Carryer PW; O'Rourke K; Andrews DF; Blair JE; Cangemi JR; Cohen Z; Cullen JB
    Gastroenterology; 1995 Aug; 109(2):404-13. PubMed ID: 7615189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.
    Brignola C; Cottone M; Pera A; Ardizzone S; Scribano ML; De Franchis R; D'Arienzo A; D'Albasio G; Pennestri D
    Gastroenterology; 1995 Feb; 108(2):345-9. PubMed ID: 7835575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
    D'Haens GR; Rutgeerts PJ
    Acta Gastroenterol Belg; 1994; 57(5-6):311-3. PubMed ID: 7709700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative recurrence in Crohn's disease].
    Caprilli R; Taddei G; Viscido A
    Chir Ital; 1995; 47(5):25-32. PubMed ID: 9162601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
    Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
    Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
    Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR; Mays DA
    Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
    J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
    Rutgeerts P
    Neth J Med; 1994 Aug; 45(2):60-4. PubMed ID: 7936007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for prevention of post-operative recurrence of Crohn's disease.
    Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug choice in preventing postoperative Crohn's disease.
    Korelitz BI
    Gastroenterology; 1996 Feb; 110(2):652-3. PubMed ID: 8566620
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
    Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
    Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Andreoli A; Capurso L; Corrao G; D'Albasio G; Gioieni A; Assuero Lanfranchi G; Paladini I; Pallone F; Ponti V
    Aliment Pharmacol Ther; 1994 Feb; 8(1):35-43. PubMed ID: 8186345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of recurrent Crohn's disease.
    van Hogezand RA; Bemelman WA
    Neth J Med; 1998 Dec; 53(6):S32-8. PubMed ID: 9883012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis.
    Tremaine WJ; Schroeder KW; Harrison JM; Zinsmeister AR
    J Clin Gastroenterol; 1994 Dec; 19(4):278-82. PubMed ID: 7876505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
    Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.